Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

73.93
Delayed Data
As of May 22
 +2.26 / +3.15%
Today’s Change
31.38
Today|||52-Week Range
80.11
+97.46%
Year-to-Date

Stock Price Forecast

The 17 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 56.00, with a high estimate of 118.00 and a low estimate of 42.00. The median estimate represents a -24.25% decrease from the last price of 73.93.

Analyst Recommendations

The current consensus among 18 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.24
Sales
$23.6M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.75%
 
 
 
 
 
 
Growthannually -11.01%
 
 
 
 
 
 

Sales

Growthquarterly 24.61%
 
 
 
 
 
 
Growthannually 74.27%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.